ClinicalTrials.Veeva

Menu

Neuroplasticity in Maternal Opioid Use Disorder (OUD)

Yale University logo

Yale University

Status

Enrolling

Conditions

Opioid Use Disorder

Treatments

Behavioral: ERPs with electroencephalography (EEG)
Behavioral: MIO

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05495984
2000033065

Details and patient eligibility

About

Opioid use disorder (OUD) remains a major public health problem particularly for mothers in the perinatal period, for whom stress, relapse rates, and risk for overdose are elevated. The perinatal period is characterized by significant neural reorganization that determines outcomes for mothers and infants. OUD is also associated with neural reorganization, specifically neural circuitry implicated in stress regulation and reward processes. Interventions should therefore take advantage of this changing perinatal biology to enhance treatment response by targeting the aberrant neural circuitry compromised by maternal OUD. The investigators have developed and refined an evidence-based intervention for mothers with OUD designed to target these neural mechanisms and enhance the reward of caregiving; however, this has yet to be formally tested. Therefore, the investigators will examine maternal neuroplasticity using high-dense array electroencephalography (EEG) in mothers with OUD in response to our intervention. There will be 1 laboratory visit at pre-treatment, followed by 12 sessions of the evidence-based parenting intervention, and 1 laboratory visit at post-treatment. This study will attempt to validate the importance of taking advantage of the neuroplasticity in the perinatal period to optimize outcomes for mothers with OUD.

Full description

This is a study conducted at the Child Study Center (CSC) in the Yale School of Medicine. It involves mothers in treatment for OUD who are caring for infants who are 4-12 months old.

15 mothers will complete 1 study visit, which will last 2.5 hours. It will start with informed consent and then will include demographics, EEG/ERP, a multidimensional assessment of mentalization (a brief self-report questionnaire, a 5-minute speaking task, and a one-hour interview) and several clinical measures (depression, anxiety, stressful life events).

Participants will then complete 12 treatment (Mothering from the Inside Out (MIO)) visits, and 1 post-treatment data collection visit.

Visits 2-13 (1 hour each) consist of participation in Mothering from the Inside Out (MIO).

Visit 14 (2.5 hours) includes participation in the ERP paradigm and the multidimensional assessment of mentalization (a brief self-report questionnaire, a 5-minute speaking task, and a one-hour interview) and several clinical measures (depression, anxiety, stressful life events).

Enrollment

15 estimated patients

Sex

Female

Ages

21 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Biological mother of infants between 4-months and 12-months of age
  • 21-45 years of age at time of recruitment
  • Enrolled in substance use treatment and on mediation for opioid use disorder (MOUD).

Exclusion criteria

  • Incapable of giving informed consent
  • Child spends less than 50% of time in mother's custody.
  • Non-English-speaking
  • Unable to complete the study because of pending legal cases or unable to supply two forms of contact for the purpose of follow-up
  • Physiological addiction to a substance that requires detoxification, defined as difficulties with physiological withdrawal from substances (e.g. delirium tremens, shaking, nausea).

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

15 participants in 2 patient groups

Primary Objective: Event-Related Potentials (ERPs)
Experimental group
Description:
Use ERPs elicited by unknown infant face and cry stimuli to determine whether neural markers translate to maternal mentalization in mothers with opioid use disorder (OUD) at 4-12 months postpartum
Treatment:
Behavioral: ERPs with electroencephalography (EEG)
Secondary Objective: ERPs + Mothering from the Inside Out (MIO)
Experimental group
Description:
Use Event-Related Potentials (ERPs) elicited by unknown infant face and cry stimuli to determine whether neural response changes with participation in an evidence-based parenting intervention designed specifically for mothers with OUD: Mothering from the Inside Out (MIO).
Treatment:
Behavioral: MIO
Behavioral: ERPs with electroencephalography (EEG)

Trial contacts and locations

1

Loading...

Central trial contact

Amanda Lowell, PhD; Helena Rutherford, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems